|
|||||
       |
The number of new infections from the human immunodeficiency virus or HIV declined worldwide last year and over the past decade, with the sharpest declines in sub-Saharan Africa. . . . → Read More: Infographic – HIV Infections Fall in Africa. Rise in Mideast, Europe  Comments are closed  Business conditions  Africa, Asia, biomedical, Europe, grant, health care, HIV, life sciences, pharmaceuticals, statistics 
A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status Comments are closed New products, Regulations biomedical, biotechnology, chemistry, clinical trials, FDA, genomics, health care, HIV, licensing, life sciences, pharmaceuticals, physical sciences, university 
The data show falling numbers of young men and women in sub-Saharan Africa with new HIV infections since 2010, but the percentage of infected women and girls also rising over that time. . . . → Read More: Infographic – Higher HIV Burden for Women, Girls in Africa Comments are closed Business conditions Africa, biomedical, health care, HIV, life sciences, pharmaceuticals, statistics
Results from a clinical trial show an experimental one-time antibody therapy, even at low doses, lowers levels of HIV virus in people living with the disease. . . . → Read More: Trial Shows Antibody Neutralizes, Reduces HIV Virus Comments are closed New products biomedical, biotechnology, clinical trials, health care, HIV, life sciences, pharmaceuticals, U.K. 
The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes Comments are closed Joint ventures/collaborations, New products Africa, Asia, biomedical, engineering, Europe, health care, HIV, medical device, software 
A clinical trial is underway assessing a therapy for HIV infections that aims to eradicate the virus with one dose of the gene-editing technique Crispr. . . . → Read More: Clinical Trial Underway for One-Time Crispr HIV Treatment Comments are closed New products biomedical, biotechnology, clinical trials, genomics, HIV, life sciences, pharmaceuticals, university 
A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial. . . . → Read More: FDA Okays One-Time HIV Treatment Clinical Trial 2 comments - (Comments are closed) New products, Regulations biomedical, biotechnology, clinical trials, entrepreneurs, FDA, genomics, HIV, licensing, life sciences, pharmaceuticals, university
A biotechnology company received a foundation grant for an implanted device to prevent HIV infection and unwanted pregnancy in women. . . . → Read More: Gates Grant Funds HIV-Birth Control Implant Comments are closed Finance, New products Africa, biomedical, biotechnology, grant, HIV, life sciences, medical device, pharmaceuticals, preclinical, university
A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections. . . . → Read More: Cancer Immunotherapy Adapted for HIV Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, genomics, HIV, investment, licensing, life sciences, mathematics, pharmaceuticals, preclinical
The Food and Drug Administration approved a drug regimen given once a month to control HIV infections, to replace daily antiretroviral medications. . . . → Read More: Monthly HIV Drug Combo Approved by FDA One comment - (Comments are closed) New products, Regulations biomedical, FDA, HIV, life sciences, pharmaceuticals |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts